[go: up one dir, main page]

HUT66514A - Carbapenem derivatives with antibiotic effect, pharmaceutical compositions containing them and process for the production of thereof - Google Patents

Carbapenem derivatives with antibiotic effect, pharmaceutical compositions containing them and process for the production of thereof

Info

Publication number
HUT66514A
HUT66514A HU9302777D HU9302777D HUT66514A HU T66514 A HUT66514 A HU T66514A HU 9302777 D HU9302777 D HU 9302777D HU 9302777 D HU9302777 D HU 9302777D HU T66514 A HUT66514 A HU T66514A
Authority
HU
Hungary
Prior art keywords
production
pharmaceutical compositions
compositions containing
antibiotic effect
carbapenem derivatives
Prior art date
Application number
HU9302777D
Other languages
English (en)
Inventor
Michael John Betts
Gareth Morse Davies
Michael Lingard Swain
Original Assignee
Zeneca Ltd
Zeneca Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd, Zeneca Pharma Sa filed Critical Zeneca Ltd
Publication of HUT66514A publication Critical patent/HUT66514A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/568—Four-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
HU9302777D 1992-02-04 1993-02-02 Carbapenem derivatives with antibiotic effect, pharmaceutical compositions containing them and process for the production of thereof HUT66514A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929202298A GB9202298D0 (en) 1992-02-04 1992-02-04 Antibiotic compounds

Publications (1)

Publication Number Publication Date
HUT66514A true HUT66514A (en) 1994-12-28

Family

ID=10709764

Family Applications (3)

Application Number Title Priority Date Filing Date
HU9302777D HUT66514A (en) 1992-02-04 1993-02-02 Carbapenem derivatives with antibiotic effect, pharmaceutical compositions containing them and process for the production of thereof
HU9302777A HU213675B (en) 1992-02-04 1993-02-02 Process for producing carbapenem derivatives, pharmaceutical compositions containing them and intermediates
HU95P/P00201P HU211840A9 (en) 1992-02-04 1995-06-14 Antibiotic compounds

Family Applications After (2)

Application Number Title Priority Date Filing Date
HU9302777A HU213675B (en) 1992-02-04 1993-02-02 Process for producing carbapenem derivatives, pharmaceutical compositions containing them and intermediates
HU95P/P00201P HU211840A9 (en) 1992-02-04 1995-06-14 Antibiotic compounds

Country Status (34)

Country Link
US (7) US5478820A (hu)
EP (1) EP0579826B1 (hu)
JP (1) JP2730600B2 (hu)
KR (1) KR100200986B1 (hu)
CN (1) CN1036006C (hu)
AP (1) AP398A (hu)
AT (1) ATE173262T1 (hu)
AU (1) AU668133B2 (hu)
CA (1) CA2106370C (hu)
CZ (1) CZ286878B6 (hu)
DE (2) DE69322007T2 (hu)
DK (1) DK0579826T3 (hu)
ES (1) ES2123654T3 (hu)
FI (1) FI104074B1 (hu)
GB (2) GB9202298D0 (hu)
GE (1) GEP20022694B (hu)
HR (1) HRP930103B1 (hu)
HU (3) HUT66514A (hu)
IL (1) IL104588A (hu)
LU (1) LU90970I2 (hu)
MY (1) MY111685A (hu)
NL (1) NL300104I2 (hu)
NO (2) NO304315B1 (hu)
NZ (2) NZ246917A (hu)
PL (3) PL174936B1 (hu)
RU (1) RU2117659C1 (hu)
SG (1) SG48817A1 (hu)
SI (1) SI9300056B (hu)
SK (1) SK280890B6 (hu)
TW (1) TW408124B (hu)
UA (1) UA44885C2 (hu)
WO (1) WO1993015078A1 (hu)
YU (1) YU48998B (hu)
ZA (1) ZA93453B (hu)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
CA2106330A1 (en) * 1992-10-07 1994-04-08 Patrice J. Siret Antibiotic compounds
US5602118A (en) * 1993-03-16 1997-02-11 American Cyanamid Company 2-thiosubstituted carbapenems
GB9515975D0 (en) * 1995-08-04 1995-10-04 Zeneca Ltd Chemical compounds
HRP970281B1 (en) * 1996-05-28 2002-04-30 Merck & Co Inc Carbapenem antibiotic, composition and method of preparation
UA62920C2 (en) * 1996-05-28 2004-01-15 Merck & Co Inc Carbapeneme antibiotic, a composition and a method for the preparation
AR008255A1 (es) * 1996-07-12 1999-12-29 Merck & Co Inc Procedimiento para sintetizar antibioticos de carbapenem
EP0923545A1 (en) 1996-08-17 1999-06-23 Zeneca Limited 3-mercaptopyrrolidines as farnesyl protein transferase inhibitors
DE69718039T2 (de) * 1996-10-10 2003-07-31 Merck & Co., Inc. (A New Jersey Corp.) Verfahren zur herstellung von zwischenprodukten in herstellung von carbapenem-seitenketten
US5877328A (en) * 1996-10-10 1999-03-02 Merck & Co., Inc. Process for synthesizing carbapenem side chain intermediates
CA2268820A1 (en) * 1996-10-28 1998-05-07 Merck & Co., Inc. Stabilized carbapenem antibiotic compositions and method of making
NZ500955A (en) * 1997-06-16 2001-06-29 Merck & Co Inc Stabilized 1-beta-methyl-carbapenem intermediates and synthetic use
US6180783B1 (en) 1997-06-16 2001-01-30 Merck & Co., Inc. Stabilized carbapenem intermediates and improved process for carbapenem synthesis
AU736136B2 (en) * 1997-07-10 2001-07-26 Merck Sharp & Dohme Corp. Crystalline forms of antibiotic side chain intermediates
US5965747A (en) * 1997-07-10 1999-10-12 Merck & Co., Inc. Crystalline forms of antibiotic side chain intermediates
US5872250A (en) * 1997-07-30 1999-02-16 Merck & Co., Inc. Process for synthesizing carbapenem antibiotics
AU749234B2 (en) * 1998-03-02 2002-06-20 Merck Sharp & Dohme Corp. Process for synthesizing carbapenem antibiotics
US6504027B1 (en) 1998-03-02 2003-01-07 Merck & Co., Inc. Decarboxylation process for synthesizing carbapenem antibiotics
AU744644B2 (en) 1998-06-17 2002-02-28 Merck & Co., Inc. Process for the synthesis of carbapenem intermediates, and compounds produced
TWI250160B (en) * 1999-07-06 2006-03-01 Sankyo Co Crystalline 1-methylcarbapenem compound
US6486150B2 (en) 1999-10-29 2002-11-26 Merck & Co., Inc. Process for formulation of antibiotic compounds
US6548492B1 (en) 1999-10-29 2003-04-15 Merck & Co., Inc. Process for formulation of carbapenem antibiotic compositions
GB9930318D0 (en) 1999-12-22 2000-02-09 Zeneca Ltd Novel compounds
GB9930317D0 (en) * 1999-12-22 2000-02-09 Zeneca Ltd Novel compounds
AU2002215212B2 (en) * 2000-11-16 2004-10-14 Sankyo Company, Limited 1-methylcarbapenem derivatives
ES2278819T3 (es) * 2000-11-24 2007-08-16 Meiji Seika Kaisha, Ltd. Nuevos derivados del carbapenem.
AR035728A1 (es) * 2001-01-16 2004-07-07 Merck & Co Inc Proceso perfeccionado para la sintesis de carbapenem
EP1442038A4 (en) * 2001-09-26 2005-01-05 Merck & Co Inc CRYSTALLINE FORMS OF CARBAPENEM ANTIBIOTICS AND MANUFACTURING METHOD
DK1474426T3 (da) * 2001-09-26 2011-11-21 Merck Sharp & Dohme Fremgangsmåde til fremstilling af carbapenemforbindelser
WO2003072015A2 (en) * 2001-11-08 2003-09-04 Merck & Co., Inc. Compounds useful in the treatment of anthrax
EP2316469A1 (en) 2002-02-22 2011-05-04 Shire LLC Delivery system and methods for protecting and administering dextroamphetamine
HRP20041138A2 (en) * 2002-05-29 2005-04-30 Merck & Co. Inc. Compounds useful in the treatment of anthrax and inhibiting lethal factor
US7845870B2 (en) * 2004-05-07 2010-12-07 Infinum Labs, Inc. Multi-position multi-level user interface system
AU2005250351A1 (en) * 2004-05-11 2005-12-15 Merck & Co., Inc. Process for making n-sulfonated-amino acid derivatives
US20100003276A1 (en) * 2004-12-07 2010-01-07 Hermes Jeffery D Methods for treating anthrax and inhibiting lethal factor
CN100344613C (zh) * 2005-10-20 2007-10-24 上海交通大学 (2s,4s)－1－(4－硝基苄氧羰基)－2－[(3－烯丙氧羰基)－苯基氨基甲酰基]－吡咯烷－4－基硫醇的制备方法
AU2012233003B2 (en) * 2005-12-07 2014-12-18 Basilea Pharmaceutica Ag Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
KR101448553B1 (ko) * 2005-12-07 2014-10-13 바실리어 파마슈티카 아게 베타-락타마아제 저해제 및 모노박탐 항생물질의 유용한 조합
US8293894B2 (en) * 2006-11-20 2012-10-23 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of carbapenem antibiotic
CN101357916B (zh) * 2007-06-22 2010-12-15 山东轩竹医药科技有限公司 含有二氢咪唑甲酰胺基的培南化合物
CN101367815B (zh) * 2007-06-28 2012-07-04 山东轩竹医药科技有限公司 六元环甲酰胺取代的巯基吡咯烷碳青霉烯化合物
CN101367807B (zh) * 2007-06-28 2011-01-12 山东轩竹医药科技有限公司 被巯基吡咯烷甲酰胺基吡啶取代的培南衍生物
CN101362760B (zh) * 2007-08-07 2010-12-15 山东轩竹医药科技有限公司 1β-甲基碳代青霉烯化合物
CN101362761B (zh) * 2007-08-12 2011-05-18 山东轩竹医药科技有限公司 含有巯基哌啶的碳代青霉烯抗生素
CN101412720B (zh) * 2007-08-27 2011-05-18 山东轩竹医药科技有限公司 含有巯基氮杂环乙烯基的碳青霉烯化合物
CN101376641B (zh) * 2007-08-28 2010-12-08 上海医药工业研究院 碳青霉烯类青霉素厄他培南的中间体及其制备方法和应用
EP2505190A1 (en) 2008-06-11 2012-10-03 Ranbaxy Laboratories Limited Polymorphic forms of ertapenem monosodium salt and process for it's preparation
DK2326648T3 (da) * 2008-07-30 2012-10-15 Ranbaxy Lab Ltd Fremgangsmåde til fremstillingen af carbapenemforbindelser
BRPI0913709A2 (pt) * 2008-09-18 2015-10-13 Manu Chaudhary "formulação farmacêutica"
WO2010124531A1 (zh) 2009-04-30 2010-11-04 石药集团中奇制药技术（石家庄）有限公司 一种厄他培南中间体、含其的组合物及其制备方法
WO2011048583A1 (en) 2009-10-23 2011-04-28 Ranbaxy Laboratories Limited Process for the preparation of carbapenem compounds
US8729260B2 (en) 2010-05-19 2014-05-20 Savior Lifetec Corporation Process for the preparation of carbapenem using cabapenem intermediates and recovery of cabapenem
CN102558182B (zh) 2010-12-31 2015-02-11 石药集团中奇制药技术（石家庄）有限公司 一种厄他培南钠晶型及其制备方法
US8691803B2 (en) 2011-01-24 2014-04-08 Savior Lifetec Corporation Process for the preparation of antibiotic compounds
WO2013121279A2 (en) * 2012-02-14 2013-08-22 Aurobindo Pharma Limited Process to prepare ertapenem
EP2906561A1 (en) 2012-10-12 2015-08-19 Sandoz AG Preparation of ertapenem intermediates
EP2968274B1 (en) 2013-03-15 2019-10-16 Kala Pharmaceuticals, Inc. Meropenem derivatives and uses thereof
IN2013MU03862A (hu) 2013-12-11 2015-07-31 Unimark Remedies Ltd
EP3430013B1 (en) 2016-03-16 2023-11-15 Orchid Pharma Limited Carbapenem compounds
CN106565579A (zh) * 2016-06-26 2017-04-19 宁夏海诚电化信息科技有限公司 一种尔它培南侧链生产工艺
CN110698480B (zh) * 2018-07-09 2023-09-08 武汉启瑞药业有限公司 一种厄他培南中间体的合成及纯化方法
MX2021008937A (es) * 2019-01-23 2021-11-12 Glycolysis Biomed Co Ltd Compuestos de beta-lactama o sales de los mismos para su uso en la prevencion o tratamiento de accion prolongada del trastorno del metabolismo de la glucosa.
JP2024118506A (ja) * 2023-02-21 2024-09-02 信越化学工業株式会社 オニウム塩、レジスト組成物、及びパターン形成方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4206219A (en) * 1978-10-24 1980-06-03 Merck & Co., Inc. 6- and 1-Substituted-1-carbadethiapen-2-em-3-carboxylic acid
US4232036A (en) * 1978-10-24 1980-11-04 Merck & Co., Inc. 6-, 1- and 2-Substituted-1-carbadethiapen-2-em-3-carboxylic acids
US4218462A (en) * 1978-10-24 1980-08-19 Merck & Co., Inc. 6-(1-Hydroxyethyl)-2-(2-aminoethylthio)-1-substituted-1-carbade-thiapen-2-em-3-carboxylic acids
US4208422A (en) * 1978-10-24 1980-06-17 Merck & Co., Inc. 1-Substituted-pen-2-em-3-carboxylic acids
DK165280A (da) * 1979-04-19 1980-10-20 Merck & Co Inc Fremgangsmaade til fremstilling af 2- og 6-substituerede 1-carbadethiapen-2-em-3-carboxylsyrer og mellemprodukter til brug ved udoevelse af fremgangsmaaden
US4746736A (en) * 1982-09-28 1988-05-24 Bristol-Myers Company Carbapenem antibiotics
CA1283906C (en) * 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
JPS60202886A (ja) * 1984-03-27 1985-10-14 Sankyo Co Ltd １―置換カルバペネム―３―カルボン酸誘導体
JPS60233076A (ja) * 1984-05-03 1985-11-19 Sumitomo Chem Co Ltd 新規なβ−ラクタム化合物およびその製造法
EP0182213B1 (en) * 1984-11-08 1990-09-26 Sumitomo Pharmaceuticals Company, Limited Carbapenem compounds and production thereof
FI81576C (fi) * 1984-12-25 1990-11-12 Sankyo Co Foerfarande foer framstaellning av derivat av 6-(1-hydroxietyl)-2-(1,2-disubstituerade-4-pyrrolidinyltio)-2- karbapenem-3-karboxylsyra, vilka aer anvaendbara som laekemedel.
DE3780344T2 (de) * 1986-03-27 1993-01-28 Sumitomo Pharma Beta-lactam-verbindungen und deren herstellung.
US4974544A (en) * 1986-10-07 1990-12-04 Ricoh Company, Co. Vapor deposition apparatus
US4963544A (en) * 1988-05-23 1990-10-16 Fujisawa Pharmaceutical Company, Ltd. 3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid compounds
US5194624A (en) * 1988-05-23 1993-03-16 Fujisawa Pharmaceutical Co., Ltd. Intermediates for the preparation of compounds of antimicrobial activity
GB8923844D0 (en) * 1989-10-23 1989-12-13 Fujisawa Pharmaceutical Co Carbapenem compounds
CA2036941A1 (en) * 1990-02-23 1991-08-24 Isao Kawamoto Carbapenem derivatives having antibiotic activity, their preparation and their use
US5554606A (en) * 1990-03-12 1996-09-10 Zeneca Limited Antibiotic compounds
AU644008B2 (en) * 1990-08-10 1993-12-02 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production and use
GB9107342D0 (en) * 1991-04-08 1991-05-22 Ici Plc Antibiotic compounds
GB9107341D0 (en) * 1991-04-08 1991-05-22 Ici Plc Antibiotic compounds
FI101226B (fi) * 1991-06-04 1998-05-15 Sankyo Co Menetelmä lääkeaineena käyttökelpoisten 2-£2-(karbonyyli)pyrrolidin-4- yylitio|-6-(1-hydroksietyyli)-1-metyylikarbapen-2-eemi-3-karboksyyliha ppojohdannaisten valmistamiseksi
ZA929008B (en) * 1991-12-13 1993-05-21 Bristol Myers Squibb Co Piperazinyl- and piperidinyl-cyclohexanols.
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
GB9304156D0 (en) * 1992-03-26 1993-04-21 Zeneca Ltd Antibiotic compounds
CA2091309A1 (en) * 1992-03-26 1993-09-27 Frederic H. Jung Antibiotic compounds
CA2099817A1 (en) * 1992-07-21 1994-01-22 Frederic H. Jung Antibiotic compounds
CA2099811A1 (en) * 1992-07-21 1994-01-22 Frederic H. Jung Antibiotic compounds
CA2099818A1 (en) * 1992-07-21 1994-01-22 Frederic H. Jung Antibiotic compounds
CA2106141A1 (en) * 1992-09-28 1994-03-29 Michael J. Betts Antibiotic compounds

Also Published As

Publication number Publication date
US20050209212A1 (en) 2005-09-22
US20030144264A1 (en) 2003-07-31
SK280890B6 (sk) 2000-09-12
GB9202298D0 (en) 1992-03-18
DE10299041I2 (de) 2003-06-12
HU213675B (en) 1997-09-29
AU3457493A (en) 1993-09-01
DK0579826T3 (da) 1999-07-26
NO933530D0 (no) 1993-10-01
FI930474L (fi) 1993-08-05
GB9300456D0 (en) 1993-03-03
LU90970I2 (fr) 2002-12-09
HUT64764A (en) 1994-02-28
US5652233A (en) 1997-07-29
PL174601B1 (pl) 1998-08-31
US5478820A (en) 1995-12-26
EP0579826A1 (en) 1994-01-26
GEP20022694B (en) 2002-05-10
MY111685A (en) 2000-11-30
US7041836B2 (en) 2006-05-09
CZ206793A3 (en) 1994-04-13
IL104588A (en) 1999-03-12
HRP930103B1 (en) 1999-12-31
US5856321A (en) 1999-01-05
WO1993015078A1 (en) 1993-08-05
FI104074B (fi) 1999-11-15
FI930474A0 (fi) 1993-02-03
RU2117659C1 (ru) 1998-08-20
SI9300056B (sl) 2000-02-29
AU668133B2 (en) 1996-04-26
KR100200986B1 (ko) 1999-06-15
ATE173262T1 (de) 1998-11-15
IL104588A0 (en) 1993-06-10
PL174649B1 (pl) 1998-08-31
DE69322007D1 (de) 1998-12-17
JPH06506704A (ja) 1994-07-28
CA2106370C (en) 2003-11-25
NO933530L (no) 1993-10-04
SI9300056A (en) 1993-09-30
UA44885C2 (uk) 2002-03-15
HRP930103A2 (en) 1994-12-31
SG48817A1 (en) 1998-05-18
US6521612B2 (en) 2003-02-18
AP9300480A0 (en) 1993-01-31
YU5493A (sh) 1996-05-20
CA2106370A1 (en) 1993-08-05
HU211840A9 (en) 1995-12-28
CZ286878B6 (en) 2000-07-12
DE10299041I1 (de) 2003-02-20
NL300104I1 (nl) 2002-12-02
US7342005B2 (en) 2008-03-11
US6187804B1 (en) 2001-02-13
CN1036006C (zh) 1997-10-01
NL300104I2 (nl) 2003-02-03
NO304315B1 (no) 1998-11-30
US20020042408A1 (en) 2002-04-11
PL174936B1 (pl) 1998-10-30
JP2730600B2 (ja) 1998-03-25
NO2002010I2 (no) 2005-03-11
AP398A (en) 1995-08-29
TW408124B (en) 2000-10-11
CN1079224A (zh) 1993-12-08
ES2123654T3 (es) 1999-01-16
HK1013998A1 (en) 1999-09-17
ZA93453B (en) 1993-08-05
HU9302777D0 (en) 1993-12-28
YU48998B (sh) 2003-04-30
NZ272038A (en) 1997-07-27
NZ246917A (en) 1995-09-26
EP0579826B1 (en) 1998-11-11
SK106393A3 (en) 1994-04-06
DE69322007T2 (de) 1999-04-01
NO2002010I1 (no) 2002-10-09
FI104074B1 (fi) 1999-11-15

Similar Documents

Publication Publication Date Title
HUT66514A (en) Carbapenem derivatives with antibiotic effect, pharmaceutical compositions containing them and process for the production of thereof
HUT70848A (en) 1-aminoethyl-indol derivatives, process for production thereof and pharmaceutical compositions comprising them
HUT58100A (en) Process for producing carbapenem derivatives with antibiotic effect and pharmaceutical compositions with antibiotic effect comprisings such compounds
HUT72308A (en) Thiazolidine derivatives and pharmaceutical composition containing the same, and process for their preparation
HU9303252D0 (en) New thiopyrano-pyrrole derivatives, pharmaceutical compositions containing them and process for producing them
HU9402232D0 (en) 1-benzene-sulfonyl-1,3-dihydro-indol-2-one derivatives, process for producing them and pharmaceutical compositions containing them
HUT72639A (en) Substituted thiazolidinedione derivatives, pharmaceutical compositions containing them and process for their preparation
HUT70526A (en) Indole-2-carboxylic acid derivatives, process for producing thereof and pharmaceutical compositions comprising same compounds
HUT76065A (en) Indole derivatives, pharmaceutical compositions containing them, process for producing them and their use
HU9402832D0 (en) Imidazol-4-yl-piperidine derivatives, process for producing them and pharmaceutical use of them
IL107039A0 (en) Compositions comprising nomegestrol derivatives and processes for their production
HUT64756A (en) Process for the production of quinoxaline derivatives and of pharmaceutical compositions containing them
IL97797A0 (en) Carbapenem compounds,their manufacture and pharmaceutical compositions containing them
HU9402292D0 (en) New baccatine-iii and 10-deacetyl-baccatine-iii derivatives, process for producing them and pharmaceutical compositions containing them as active component
HU9402187D0 (en) Heterocyclic compounds, process for producing them and pharmaceutical compositions containing them
HUT67142A (en) Spirostanil glycosidal cristalline monohydrate, pharmaceutical compositions containing the same and process for their production
HU9400934D0 (en) Thiadiazinone derivatives, pharmaceutical compositions containing them and process for producing them
HUT65768A (en) 17-beta-substituted 4-aza-androstane-derivatives and pharmaceutical compositions containing them and process for the production thereof
HU9303376D0 (en) Process for producing alpha, omega-diaryl-alkane derivatives and pharmaceutical compositions containing them
HUT71349A (en) Heteroaryl-piperidine derivatives, process for producing them and pharmaceutical compositions containing them
HU9303322D0 (en) Pyrrole derivatives, process for producing them and pharmaceutical compositions containing them
AU8107394A (en) 1,4,7,10-tetraazacyclododecane derivatives, their use, pharmaceuticals containing them and process for their production
HU9503345D0 (en) Substituted benzoyl-guanidine derivatives, process for producing them their use as medicine and diagnosticum and pharmaceutical composition containing them
AU695490B2 (en) 6-methoxy-1h-benzotriazole-5-carboxamide derivatives, their production processes and pharmaceutical compositions containing them
AU4756693A (en) 1-heteroarylazetidines and -pyrrolidines, process for their preparation and pharmaceutical compositions containing them